LMX1A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84140
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human LMX1A. Peptide sequence: QNQRAKMKKLARRQQQQQQDQQNTQRLSSAQTNGGGSAGMEGIMNPYTAL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for LMX1A Antibody
Western Blot: LMX1A Antibody [NBP2-84140]
Western Blot: LMX1A Antibody [NBP2-84140] - WB Suggested Anti-LMX1A Antibody. Titration: 1 ug/ml. Positive Control: 721_B Whole CellImmunohistochemistry: LMX1A Antibody [NBP2-84140]
Immunohistochemistry: LMX1A Antibody [NBP2-84140] - Rabbit Anti-LMX1A Antibody. Paraffin Embedded Tissue: Human Muscle. Cellular Data: Skeletal muscle cells. Antibody Concentration: 4.0-8.0 ug/ml. Magnification: 400XWestern Blot: LMX1A Antibody [NBP2-84140]
Western Blot: LMX1A Antibody [NBP2-84140] - Host: Rabbit. Target Name: TRIM10. Sample Type: 721_B. Antibody Dilution: 1.0ug/mlApplications for LMX1A Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: LMX1A
Alternate Names
LIM homeobox transcription factor 1, alpha, LMX1.1
Gene Symbol
LMX1A
Additional LMX1A Products
Product Specific Notices for LMX1A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...